Short communicationPublished 27 Sep 2022
Intravenous Methotrexate Prophylaxis of CNS Recurrence with B-Mobileular Lymphoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The final results of sufferers with systemic diffuse big B-mobileular lymphoma (DLBCL) had stepped forward over the last decade with the addition of monoclonal antibody remedy. Unfortunately, about five% of those sufferers nonetheless advanced a secondary vital anxious system (CNS) recurrence observed continuously with the aid of using speedy loss of life. This fee is notably expanded in sufferers with positive excessive-threat capabilities. Although prophylaxis in opposition to CNS recurrence with both intrathecal or intravenous methotrexate is generally used for such sufferers, to the authors' expertise, there may be no popular of care. Retrospectively evaluated changed into the position of excessive-dose systemic methotrexate blended with popular cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab (R-CHOP) chemotherapy to lower CNS recurrence in excessive-threat sufferers.
Subjects
Oncology & CancerSurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Surgical Oncology
- SubjectOncology & Cancer
- SubjectSurgery
- BylineArticles whose byline prints “Afshin Amini”
